[PDF] Supportive Therapy In Haematology eBook

Author : P.C. Das
Publisher : Springer Science & Business Media
Page : 402 pages
File Size : 43,56 MB
Release : 2012-12-06
Category : Medical
ISBN : 1461325773

GET BOOK

As appropriately outlined in the first chapter in cells was pioneered in Holland by Van Loghem and part II in this book, the history of contemporary Van Rood, and it led eventually to the discovery of blood transfusion is only three-quarters of a cen the HLA system and its subsequent explosive de tury old. On the surface, there is not much left in velopment. In biochemistry, the work on the ABO common between an arm to arm blood transfer and MN blood group substances has provided carried out as an heroic measure in the twenties, pointers to general features of the biosynthesis and when patient or donor had to be weighed in order role of glycolipids and glycoproteins in the cell for the physician to decide when to stop, and blood membrane, and the identification of serological component therapy of today, when several patients specificities associated with specific oligo sac can benefit from appropriately measured and stan chari des has proven for the first time how gene dardized amounts of various purified blood frac products that are not proteins can exhibit Men tions. Yet, the basic principles of blood transfusion delian inheritance.

Author : Sagar Lonial
Publisher : Springer Science & Business Media
Page : 674 pages
File Size : 25,11 MB
Release : 2009-01-01
Category : Medical
ISBN : 1597455644

GET BOOK

Therapeutic options for patients with myeloma have dramatically changed over the past 10 years. Beginning with the advances in therapy resulting from the use of high-dose therapy and autologous bone marrow or stem cell tra- plant, we have more than doubled the median survival for patients as a whole, and have now have a wealth of different biology -based treatment approaches for our patients in all disease stages. This book represents state-of-the-art information from many of the leaders in the plasma cell disorders world. Sections focusing on disease pathogenesis and biology, chemotherapy-based approaches, immune -based therapies, currently approved novel agents, developing targets, supportive care, and other plasma cell disorders provides a comprehensive collection and an excellent resource in this time of rapid change in clinical and preclinical disease knowledge. It is important to realize that these changes did not occur in a vacuum. Partnerships between academic institutions, the pharmaceutical industry, patient advocacy groups, the National Cancer Institute, community onco- gists, and ultimately our patients worked closely together to realize these advances, and to effect the radical changes in therapy we have witnessed over the past few years. This book would not have been possible without contri- tions from each of the gifted scientists and clinicians who worked tirelessly to prepare their individual chapters all the while maintaining commitment to the scientific and clinical mission of advancing care.

Author : Michael M. Boyiadzis
Publisher : McGraw Hill Professional
Page : 2892 pages
File Size : 21,6 MB
Release : 2022-02-04
Category : Medical
ISBN : 1260117413

GET BOOK

The essential therapy guide to cancer, hematologic disorders, and supportive care—updated with the latest treatment regimens A Doody's Core Title for 2023! Hematology-Oncology Therapy, Third Edition, is an up-to-date, comprehensive therapy guide that delivers more than 800 treatment regimens in a succinct, uniform format. Supported by the latest practice guidelines, peer-reviewed literature, and insights from experts in the field, this peerless resource integrates extensive information critical to both office- and hospital-based practice of hematology and oncology. Hematology-Oncology Therapy is divided into four sections: Cancer Regimens: Covers administration, toxicity, dose modification, monitoring, supportive care, and the efficacy of commonly used and recently approved therapeutic regimens, and includes expert opinion and critical information on epidemiology, pathology, work-up, and staging, as well as survival data Antiemetics, Growth Factors, Dose Modification and Drug Preparation: Provides in-depth coverage of antiemetics, growth factors, and the administration and formulation of anti-cancer drugs Supportive Care, Complications, and Screening (online): Offers thorough coverage of topics commonly encountered in clinical hematology-oncology practice Selected Hematologic Diseases (online): provides an authoritative guide to therapy for principal diseases in consultative hematology The entire content is now online at AccessHemOnc.com. The online platform created for the third edition will be continually updated, including newly approved regimens.

Author : Michael M. Boyiadzis
Publisher : McGraw Hill Professional
Page : 1889 pages
File Size : 16,99 MB
Release : 2014-05-16
Category : Medical
ISBN : 0071837051

GET BOOK

The Essential Therapy Guide to Cancer, Hematologic Disorders, and Supportive Care--Updated with the Latest Treatment Regimens More than 500 treatment regimens A Doody’s Core Title for 2019! Hematology-Oncology Therapy, Second Edition is an up-to-date, comprehensive therapy guide that delivers more than 500 treatment regimens in a succinct, uniformmanner. The unique tabular design allows you to instantly locate and implement the proper treatment regimen. Supported by the latest practice guidelines, peer-reviewed literature, and the opinion of experts, Hematology-Oncology Therapy integrates extensive informationthat is critical to both office- and hospital-based practice of hematology and oncology. Hematology-Oncology Therapy is divided into three sections: Oncology: Provides detailed information about the administration, supportive care, toxicity, dose modification, monitoring, and efficacy of commonly used and recently approvedchemotherapeutic regimens, drugs, and biological agents Supportive Care, Drug Preparation, Complications, and Screening: Consists of topics commonly encountered in clinical hematology-oncology practice, such as chemotherapy-induced nausea, oncologic emergencies, radiation complications, cancer pain management, cancer screening, and much more Selected Hematologic Diseases: Delivers an authoritative guide to therapy for the principal diseases in consultative hematology This edition of Hematology-Oncology Therapy is enriched by the updating of all chapters as well as the addition of several new chapters; the new "Expert Opinion," which provides recommendations and guidance from experts on the use of treatment regimens; and inclusion of the latest regimens.

Author : Everett E. Vokes
Publisher : Springer Science & Business Media
Page : 686 pages
File Size : 22,81 MB
Release : 2011-06-28
Category : Medical
ISBN : 3642557805

GET BOOK

This second edition has been updated in a user-friendly layout that makes its comprehensive information extremely accessible. The handbook, written for all physicians who treat cancer patients, provides a survey of current therapeutic concepts of solid tumors and hematologic malignancies in internal oncology. Each individual chapter of this shortened new edition is structured in the same way and features a brief outline or tabular summary of the main aspects of epidemiology, pathology, staging, and diagnosis. The main focus is on the therapeutic strategy, i.e., an interdisciplinary approach to systemic drug therapy. Surgical and radiological concepts of treatment are also covered, as are supportive care, pain relief methods and ethical problems. This title is a must for clinicians and practitioners as well as interns, residents and postgraduate students.

Author : Michael Boyiadzis
Publisher : McGraw-Hill Professional
Page : 932 pages
File Size : 24,70 MB
Release : 2007
Category : Medical
ISBN :

GET BOOK

The first clinical manual to bridge the disciplines of hematology and oncology A Doody's Core Title! Hematology-Oncology Therapy integrates an extensive amount of information ( 67 chapters ) that is critical to both office- and hospital-based clinical practice of hematology and oncology. This comprehensive approach makes the book invaluable to all practitioners involved in the care of patients with cancer or hematologic diseases. The three sections of Hematology-Oncology Therapy are: Oncology Supportive Care, Drug Preparation, Complications, and Screening Selected Hematologic Diseases Section I provides detailed information about the administration, emetogenic potential, toxicity, dose modification, monitoring, and efficacy of commonly used and recently approved chemotherapeutic regimens or drugs and biological agents. In addition, each chapter, focused on a specific cancer, contains information about epidemiology, pathology, work-up, and staging, as well as survival data. Section II consists of topics commonly encountered in clinical hematology-oncology practice. Section III provides an authoritative guide to therapy for the principal diseases in consultative hematology.

Author : Miguel-Angel Perales
Publisher : Springer
Page : 288 pages
File Size : 23,79 MB
Release : 2018-12-31
Category : Medical
ISBN : 9783319543673

GET BOOK

In this book, experts in the field express their well-reasoned opinions on a range of complex, clinically relevant issues across the full spectrum of cell and gene therapies with the aim of providing trainee and practicing hematologists, including hematopoietic transplant physicians, with information that is relevant to clinical practice and ongoing research. Each chapter focuses on a particular topic, and the concise text is supported by numerous working tables, algorithms, and figures. Whenever appropriate, guidance is provided regarding the availability of potentially high-impact clinical trials. The rapid evolution of cell and gene therapies is giving rise to numerous controversies that need to be carefully addressed. In meeting this challenge, this book will appeal to all residents, fellows, and faculty members responsible for the care of hematopoietic cell transplant patients. It will also offer a robust, engaging tool to aid vital activities in the daily work of every hematology and oncology trainee.

Author : Mahmoud Aljurf
Publisher : Springer Nature
Page : 192 pages
File Size : 38,52 MB
Release : 2021-10-28
Category : Medical
ISBN : 3030820521

GET BOOK

This open access book provides a valuable resource for hospitals, institutions, and health authorities worldwide in their plans to set up and develop comprehensive cancer care centers. The development and implementation of a comprehensive cancer program allows for a systematic approach to evidence-based strategies of prevention, early detection, diagnosis, treatment, and palliation. Comprehensive cancer programs also provide a nexus for the running of clinical trials and implementation of novel cancer therapies with the overall aim of optimizing comprehensive and holistic care of cancer patients and providing them with the best opportunity to improve quality of life and overall survival. This book's self-contained chapter format aims to reinforce the critical importance of comprehensive cancer care centers while providing a practical guide for the essential components needed to achieve them, such as operational considerations, guidelines for best clinical inpatient and outpatient care, and research and quality management structures. Intended to be wide-ranging and applicable at a global level for both high and low income countries, this book is also instructive for regions with limited resources. The Comprehensive Cancer Center: Development, Integration, and Implementation is an essential resource for oncology physicians including hematologists, medical oncologists, radiation oncologists, surgical oncologists, and oncology nurses as well as hospitals, health departments, university authorities, governments and legislators.

Author : Laurent Degos
Publisher : CRC Press
Page : 1492 pages
File Size : 35,86 MB
Release : 2004-12-14
Category : Medical
ISBN : 1841841455

GET BOOK

The Second Edition of this successful title has been fully revised and updated and now includes expanded sections on normal and malignant haematopoiesis, offering a thorough review of the molecular and cellular processes involved in malignancy, developments in diagnostic techniques and treatment, concluding with discussion of treatment of individual diseases, late effects of therapy and supportive care. Short Contents